Association of kidney disease with prevalent gout in the United States in 1988-1994 and 2007-2010

Seminars in Arthritis and Rheumatism

Volumn 42, Issue 6, 2013, Pages 551-561

  Juraschek, Stephen P ^a,b,c   Kovell, Lara C ^c   Miller, Edgar R ^a,b,c   Gelber, Allan C ^a,b,c  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Albuminuria; Chronic kidney disease; Glomerular filtration rate; Gout; NHANES

Indexed keywords

ALBUMIN; ALLOPURINOL; CARBONATE DEHYDRATASE INHIBITOR; COLCHICINE; LOOP DIURETIC AGENT; OXIPURINOL; POTASSIUM SPARING DIURETIC AGENT; PROBENECID; SULFINPYRAZONE; THIAZIDE DIURETIC AGENT; URIC ACID;

ADULT; AGED; ALBUMINURIA; ARTHRALGIA; ARTICLE; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; GLOMERULUS FILTRATION RATE; GOUT; HEALTH SURVEY; HUMAN; JOINT SWELLING; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; SELF REPORT; UNITED STATES; URIC ACID BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; COMORBIDITY; CROSS-SECTIONAL STUDIES; FEMALE; GLOMERULAR FILTRATION RATE; GOUT; HUMANS; KIDNEY DISEASES; MALE; MIDDLE AGED; NUTRITION SURVEYS; PREVALENCE; UNITED STATES;

EID: 84881252756     PISSN: 00490172     EISSN: 1532866X     Source Type: Journal    
DOI: 10.1016/j.semarthrit.2012.09.009     Document Type: Article

References (55)

1. Zhu Y., Pandya B.J., Choi H.K. Prevalence of gout and hyperuricemia in the US general population: The National Health and Nutrition Examination Survey 2007-2008. Arthritis Rheum 2011, 63(10):3136-3141.
2. Juraschek SP, Miller ER 3rd, Gelber AC. Body mass index, obesity, and prevalent gout in the United States in 1988-1994 and 2007-2010: Body Mass Index. Obesity Gout Arthritis Care Res [Internet]. 2012 Jul 6 [cited 2012 Jul 18]; Available from: http://www.ncbi.nlm.nih.gov/pubmed/22778033.
3. Choi H.K., Ford E.S., Li C., Curhan G. Prevalence of the metabolic syndrome in patients with gout: The Third National Health and Nutrition Examination Survey. Arthritis Rheum 2007, 57(1):109-115.
4. Coresh J., Selvin E., Stevens L.A., Manzi J., Kusek J.W., Eggers P., et al. Prevalence of chronic kidney disease in the United States. J Am Med Assoc 2007, 298(17):2038-2047.
5. Lipkowitz M.S. Regulation of uric acid excretion by the kidney. Curr Rheumatol Rep 2012, 14(2):179-188.
6. Ryu S., Chang Y., Zhang Y., Kim S.-G., Cho J., Son H.J., et al. A cohort study of hyperuricemia in middle-aged South Korean men. Am J Epidemiol 2012, 175(2):133-143.
7. Toto R.D., Greene T., Hebert L.A., Hiremath L., Lea J.P., Lewis J.B., et al. Relationship between body mass index and proteinuria in hypertensive nephrosclerosis: results from the African American Study of Kidney Disease and Hypertension (AASK) cohort. Am J Kidney Dis 2010, 56(5):896-906.
8. Chen N., Wang W., Huang Y., Shen P., Pei D., Yu H., et al. Community-based study on CKD subjects and the associated risk factors. Nephrol Dial Transplant 2009, 24(7):2117-2123.
9. Sorensen L.B. Role of the intestinal tract in the elimination of uric acid. Arthritis Rheum 1965, 8(5):694-706.
10. Campion E.W., Glynn R.J., DeLabry L.O. Asymptomatic hyperuricemia. Risks and consequences in the Normative Aging Study. Am J Med 1987, 82(3):421-426.
11. Sorensen L.B. The pathogenesis of gout. Arch Intern Med 1962, 109:379-390.
12. Talbott J.H., Terplan K.L. The kidney in gout. Medicine (Baltimore) 1960, 39:405-467.
13. Vecchio P.C., Emmerson B.T. Gout due to renal disease. Br J Rheumatol 1992, 31(1):63-65.
14. Sheane B.J., Cunnane G. Tophaceous gout and chronic kidney disease. J Clin Rheumatol 2007, 13(5):293.
15. Medeiros MMC, Silva GB Jr, Daher EF. Tophus gout and chronic kidney disease in a young female patient: Report of familial juvenile hyperuricemic nephropathy in three generations of the same family. Rheumatol Int [Internet]. 2011 Sep 10 [cited 2012 Mar 24]; Available from: http://www.ncbi.nlm.nih.gov/pubmed/21909621.
16. Gibson T., Highton J., Potter C., Simmonds H.A. Renal impairment and gout. Ann Rheum Dis 1980, 39(5):417-423.
17. Choi H.K., Atkinson K., Karlson E.W., Curhan G. Obesity, weight change, hypertension, diuretic use, and risk of gout in men: the health professionals follow-up study. Arch Intern Med 2005, 165(7):742-748.
18. Zhu Y., Pandya B.J., Choi H.K. Comorbidities of Gout and Hyperuricemia in the US General Population: NHANES 2007-2008. Am J Med 2012, 125(7):679-687. e1.
19. Centers for Disease Control. NHANES - NHANES III - Reports and Reference Manuals [Internet]. 1988 [cited 2011 Nov 22]. Available from: http://www.cdc.gov/nchs/nhanes/nh3rrm.htm.
20. Centers for Disease Control. NHANES - NHANES 1999-2010 - Manuals, Brochures, and Consent Documents [Internet]. 1999 [cited 2011 Nov 22]. Available from: http://www.cdc.gov/nchs/nhanes/.
21. McAdams M.A., Maynard J.W., Baer A.N., Köttgen A., Clipp S., Coresh J., et al. Reliability and sensitivity of the self-report of physician-diagnosed gout in the campaign against cancer and heart disease and the atherosclerosis risk in the community cohorts. J Rheumatol 2011, 38(1):135-141.
22. Levey A.S., Stevens L.A., Schmid C.H., Zhang Y.L., Castro A.F., Feldman H.I., et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009, 150(9):604-612.
23. Selvin E., Manzi J., Stevens L.A., Van Lente F., Lacher D.A., Levey A.S., et al. Calibration of serum creatinine in the National Health and Nutrition Examination Surveys (NHANES) 1988-1994, 1999-2004. Am J. Kidney Dis 2007, 50(6):918-926.
24. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002;39(2 Suppl 1):S1-266.
25. Egan B.M., Zhao Y., Axon R.N. US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. J Am Med Assoc 2010, 303(20):2043-2050.
26. National Heart Lung and Blood Institute. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [Internet]. 2002 Sep. Report No.: NIH Publication No. 02-5215. Available from: http://www.nhlbi.nih.gov/guidelines/cholesterol/atp3full.pdf.
27. Feig D.I., Kang D.-H., Johnson R.J. Uric acid and cardiovascular risk. N Engl J Med 2008, 359(17):1811-1821.
28. Tsai J., Ford E.S., Li C., Zhao G. Past and current alcohol consumption patterns and elevations in serum hepatic enzymes among US adults. Addict Behav 2012, 37(1):78-84.
29. Maesaka J.K., Fishbane S. Regulation of renal urate excretion: A critical review. Am J Kidney Dis 1998, 32(6):917-933.
30. Marangella M. Uric acid elimination in the urine. Pathophysiological implications. Contrib Nephrol 2005, 147:132-148.
31. Rieselbach R.E. Renal handling of uric acid. Adv Exp Med Biol 1977, 76B:1-22.
32. García Puig J., Mateos Antón F., López Jiménez M., Conthe Gutiérrez P. Renal handling of uric acid in gout: impaired tubular transport of urate not dependent on serum urate levels. Metab Clin Exp 1986, 35(12):1147-1153.
33. Kang D.-H., Chen W. Uric acid and chronic kidney disease: new understanding of an old problem. Semin Nephrol 2011, 31(5):447-452.
34. Mazzali M., Hughes J., Kim Y.G., Jefferson J.A., Kang D.H., Gordon K.L., et al. Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension 2001, 38(5):1101-1106.
35. Nakagawa T., Mazzali M., Kang D.-H., Kanellis J., Watanabe S., Sanchez-Lozada L.G., et al. Hyperuricemia causes glomerular hypertrophy in the rat. Am J Nephrol 2003, 23(1):2-7.
36. Gonick H.C., Rubini M.E., Gleason I.O., Sommers S.C. The Renal Lesion in Gout. Ann Intern Med 1965, 62:667-674.
37. Sturm G., Kollerits B., Neyer U., Ritz E., Kronenberg F. Uric acid as a risk factor for progression of non-diabetic chronic kidney disease? The Mild to Moderate Kidney Disease (MMKD) Study. Exp Gerontol 2008, 43(4):347-352.
38. Hunsicker L.G., Adler S., Caggiula A., England B.K., Greene T., Kusek J.W., et al. Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study. Kidney Int 1997, 51(6):1908-1919.
39. Iseki K., Ikemiya Y., Inoue T., Iseki C., Kinjo K., Takishita S. Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort. Am J Kidney Dis 2004, 44(4):642-650.
40. Ohno I., Hosoya T., Gomi H., Ichida K., Okabe H., Hikita M. Serum uric acid and renal prognosis in patients with IgA nephropathy. Nephron 2001, 87(4):333-339.
41. Syrjänen J., Mustonen J., Pasternack A. Hypertriglyceridaemia and hyperuricaemia are risk factors for progression of IgA nephropathy. Nephrol Dial Transplant 2000, 15(1):34-42.
42. Tomita M., Mizuno S., Yamanaka H., Hosoda Y., Sakuma K., Matuoka Y., et al. Does hyperuricemia affect mortality? A prospective cohort study of Japanese male workers. J Epidemiol 2000, 10(6):403-409.
43. Siu Y.-P., Leung K.-T., Tong M.K.-H., Kwan T.-H. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level. Am J Kidney Dis 2006, 47(1):51-59.
44. Goicoechea M., de Vinuesa S.G., Verdalles U., Ruiz-Caro C., Ampuero J., Rincón A., et al. Effect of allopurinol in chronic kidney disease progression and cardiovascular risk. Clin J Am Soc Nephrol 2010, 5(8):1388-1393.
45. Momeni A., Shahidi S., Seirafian S., Taheri S., Kheiri S. Effect of allopurinol in decreasing proteinuria in type 2 diabetic patients. Iran J Kidney Dis 2010, 4(2):128-132.
46. Gibson T., Rodgers V., Potter C., Simmonds H.A. Allopurinol treatment and its effect on renal function in gout: A controlled study. Ann Rheum Dis 1982, 41(1):59-65.
47. Noman A., Ang D.S.C., Ogston S., Lang C.C., Struthers A.D. Effect of high-dose allopurinol on exercise in patients with chronic stable angina: a randomised, placebo controlled crossover trial. Lancet 2010, 375(9732):2161-2167.
48. Simkin P.A. Urate excretion in normal and gouty men. Adv Exp Med Biol 1977, 76B:41-45.
49. Kang D.-H., Nakagawa T., Feng L., Watanabe S., Han L., Mazzali M., et al. A role for uric acid in the progression of renal disease. J Am Soc Nephrol 2002, 13(12):2888-2897.
50. Dykeman-Sharpe J. Treatment of acute gouty arthritis in patients with chronic kidney disease. CANNT J 2004, 14(1):48-50.
51. El-Zawawy H., Mandell B.F. Managing gout: How is it different in patients with chronic kidney disease?. Cleve Clin J Med 2010, 77(12):919-928.
52. Wallace S.L., Robinson H., Masi A.T., Decker J.L., McCarty D.J., Yü T.F. Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum 1977, 20(3):895-900.
53. O'Sullivan J.B. Gout in a New England town. A prevalence study in Sudbury, Massachusetts. Ann Rheum Dis 1972, 31(3):166-169.
54. Choi H.K., Atkinson K., Karlson E.W., Willett W., Curhan G. Purine-rich foods, dairy and protein intake, and the risk of gout in men. N Engl J Med 2004, 350(11):1093-1103.
55. Sarraf P., Kay J., Reginato A.M. Non-crystalline and crystalline rheumatic disorders in chronic kidney disease. Curr Rheumatol Rep 2008, 10(3):235-248.